Literature DB >> 14563530

Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline.

Jacek Piosik1, Katarzyna Ulanowska, Anna Gwizdek-Wiśniewska, Agata Czyz, Jan Kapuściński, Grzegorz Wegrzyn.   

Abstract

Previous studies performed by others indicated that apart from its other biological effects, caffeine (CAF) may have a role in protection of organisms against cancer. However, biological mechanism of this phenomenon remained unknown. Recent studies suggested that caffeine can form stacking (pi-pi) complexes with polycyclic aromatic chemicals. Therefore, one might speculate that effective concentrations of polycyclic aromatic mutagens could be reduced in the presence of caffeine. Here we demonstrate that caffeine and another xanthine, pentoxifylline (PTX), effectively alleviate mutagenic action of polycyclic aromatic agents (exemplified by quinacrine mustard (QM), 2-methoxy-6-chloro-9-(3-(2-chloroethyl)aminopropylamino)acridine.2HCl (ICR-191) and 1,3,7-propanediamine-N-(2-chloroethyl)-N'-(6-chloro-2-methoxy-9-acridinyl)-N-ethyl.2HCl (ICR-170)), but not of aliphatic mutagens (exemplified by mechlorethamine), in the recently developed mutagenicity test based on bacterium Vibrio harveyi. Biophysical studies indicated that caffeine and pentoxifylline can form stacking complexes with the aromatic agents mentioned above. Molecular modeling also confirmed a possibility of stacking interactions between examined molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563530     DOI: 10.1016/s0027-5107(03)00136-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  Attenuation of acridine mutagen ICR-191--DNA interactions and DNA damage by the mutagen interceptor chlorophyllin.

Authors:  Monika Pietrzak; H Dorota Halicka; Zbigniew Wieczorek; Jolanta Wieczorek; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2008-03-30       Impact factor: 2.352

2.  Quantification of the interceptor action of caffeine on the in vitro biological effect of the anti-tumour agent topotecan.

Authors:  M P Evstigneev; A A Mosunov; V P Evstigneev; H G Parkes; D B Davies
Journal:  Eur Biophys J       Date:  2011-06-15       Impact factor: 1.733

3.  Complexation of anthracycline drugs with DNA in the presence of caffeine.

Authors:  M P Evstigneev; V V Khomich; D B Davies
Journal:  Eur Biophys J       Date:  2006-10-24       Impact factor: 1.733

4.  Complexation of biologically active aromatic compounds with DNA in the presence of theophylline.

Authors:  A A Hernandez Santiago; D D Andrejuk; A M Cervantes Tavera; D B Davies; M P Evstigneev
Journal:  J Biol Phys       Date:  2009-01-10       Impact factor: 1.365

5.  Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  Katarzyna Ulanowska; Grzegorz Wegrzyn
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

6.  Spectroscopic study of porphyrin-caffeine interactions.

Authors:  Magdalena Makarska-Bialokoz
Journal:  J Fluoresc       Date:  2012-07-05       Impact factor: 2.217

7.  Preliminary mutagenicity and genotoxicity evaluation of selected arylsulfonamide derivatives of (aryloxy)alkylamines with potential psychotropic properties.

Authors:  Beata Powroźnik; Karolina Słoczyńska; Vittorio Canale; Katarzyna Grychowska; Paweł Zajdel; Elżbieta Pękala
Journal:  J Appl Genet       Date:  2015-10-06       Impact factor: 3.240

Review 8.  Antimutagenic compounds and their possible mechanisms of action.

Authors:  Karolina Słoczyńska; Beata Powroźnik; Elżbieta Pękala; Anna M Waszkielewicz
Journal:  J Appl Genet       Date:  2014-03-11       Impact factor: 3.240

9.  In Vitro Biotransformation, Safety, and Chemopreventive Action of Novel 8-Methoxy-Purine-2,6-Dione Derivatives.

Authors:  Małgorzata Anna Marć; Enrique Domínguez-Álvarez; Karolina Słoczyńska; Paweł Żmudzki; Grażyna Chłoń-Rzepa; Elżbieta Pękala
Journal:  Appl Biochem Biotechnol       Date:  2017-06-17       Impact factor: 2.926

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.